JPRN-C000000046Completed未知
A phase I/II study of percutaneous radiofrequency ablation for malignant tumor in the pelvis (JIVROSG-0204) - Percutaneous radiofrequency ablation for intrapelvic tumor (JIVROSG-0204)
Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 sites33 target enrollmentStarted: August 6, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 33
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) No symptom or VAS of less than 3. 2) Cardiac pacemaker. 3) Artery or nerve along the puncture route. 4) Lesion or target area adjacent to critical organs. 5) Infection in the target area. 6) Pregnancy.
Investigators
Similar Trials
Completed
Not Applicable
A phase I/II study of percutaneous radiofrequency ablation for osteoid osteoma (JIVROSG-0704)osteoid osteomaJPRN-UMIN000001501Japan Interventional Radiology in Oncology Study Group (JIVROSG)21
Completed
Phase 1
A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)Symptomatic metastatic bone tumorJPRN-C000000047Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
Completed
Phase 2
A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)Malignant lung tumorJPRN-UMIN000001502Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
Completed
Phase 1
A phase II study of percutaneous radiofrequency ablation for malignant reanl tumor (JIVROSG-0701)malignant renal tumorJPRN-UMIN000001123Japan Interventional Radiology in Oncology Study Group (JIVROSG)33
Recruiting
Not Applicable
Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancerprimary or metastatic lung cancerJPRN-UMIN000005957Oita University Faculty of Medicine, Department of Radiology20